Briacell Total Assets from 2010 to 2026
| BCT Stock | 5.97 0.28 4.48% |
Total Assets | First Reported 2006-10-31 | Previous Quarter 21.6 M | Current Value 13.1 M | Quarterly Volatility 13.8 M |
Check Briacell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Briacell Therapeutics' main balance sheet or income statement drivers, such as Other Operating Expenses of 45.6 M, Total Operating Expenses of 45.4 M or Depreciation And Amortization of 178.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.19. Briacell financial statements analysis is a perfect complement when working with Briacell Therapeutics Valuation or Volatility modules.
Briacell | Total Assets |
Latest Briacell Therapeutics' Total Assets Growth Pattern
Below is the plot of the Total Assets of Briacell Therapeutics Corp over the last few years. Total assets refers to the total amount of Briacell Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Briacell Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Briacell Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Briacell Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 21.65 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Briacell Total Assets Regression Statistics
| Arithmetic Mean | 13,863,806 | |
| Geometric Mean | 4,453,351 | |
| Coefficient Of Variation | 123.24 | |
| Mean Deviation | 13,798,874 | |
| Median | 5,872,261 | |
| Standard Deviation | 17,086,280 | |
| Sample Variance | 291.9T | |
| Range | 57.9M | |
| R-Value | 0.54 | |
| Mean Square Error | 221.9T | |
| R-Squared | 0.29 | |
| Significance | 0.03 | |
| Slope | 1,813,875 | |
| Total Sum of Squares | 4671.1T |
Briacell Total Assets History
About Briacell Therapeutics Financial Statements
Briacell Therapeutics investors utilize fundamental indicators, such as Total Assets, to predict how Briacell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 24.9 M | 26.1 M | |
| Intangibles To Total Assets | 0.01 | 0.01 |
Pair Trading with Briacell Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Briacell Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Briacell Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Briacell Stock
| 0.72 | AX-UN | Artis Real Estate | PairCorr |
| 0.67 | FFH-PI | Fairfax Financial | PairCorr |
| 0.63 | ENB-PFU | Enbridge Pref L | PairCorr |
| 0.62 | FFH | Fairfax Financial | PairCorr |
| 0.58 | KTO | K2 Gold | PairCorr |
The ability to find closely correlated positions to Briacell Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Briacell Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Briacell Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Briacell Therapeutics Corp to buy it.
The correlation of Briacell Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Briacell Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Briacell Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Briacell Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Briacell Therapeutics Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.